Conduction of Clinical Trials Phase 1-IV (for small and large molecules) with access to large database of patients with various disease areas.
Conduction of BA/BE studies with large data base of over 3,000 of healthy volunteers.
Triumpharma conducted many clinical trials and BA/BE studies covering biotech / biosimilars / super- generics / small molecules ranging from conventional dosage forms to Long-Acting Injectables, infusion, thin film , transdermal patches, ODT, inhalers, injectables, etc. Triumpharma has its own phase I unit with over 80 beds and a dedicated wing in a hospital with over 17 beds for studies that requires hospitalized settings.
Triumpharma has demonstrated fast recruitment time and rate and very quick turn around time for randomization and dosing.